1040: Michigan’s Chief Medical Executive Discusses the Stakes of ACIP’s Vote on Hepatitis B Vaccine for Newborns
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
1040: Michigan’s Chief Medical Executive Discusses the Stakes of ACIP’s Vote on Hepatitis B Vaccine for Newborns
-
ナレーター：
-
著者：
このコンテンツについて
In this episode, ASTHO member and Michigan Department of Health & Human Services Chief Medical Executive Dr. Natasha Bagdasarian breaks down a major development in national vaccine policy: the CDC Advisory Committee on Immunization Practices’ decision to narrow its guidance on the hepatitis B birth dose. Dr. Bagdasarian, who serves as ASTHO’s liaison to the Advisory Committee on Immunization Practices, shares why the shift toward “individual decision-making” raises concerns for newborn safety, health equity, and public trust in vaccines. She discusses the vulnerabilities in our health system that could leave some infants unprotected, how localized transmission risks extend beyond maternal infection, and why softening long-standing guidance may unintentionally fuel doubt about other vaccines. Dr. Bagdasarian also explains why Michigan—and many other states—are choosing to follow the American Academy of Pediatrics’ recommendation to continue the universal birth dose.
Designing for Connection Webinar Series | ASTHOHome | Public Health Careers.org